$455 Million is the total value of SABBY MANAGEMENT, LLC's 124 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 53.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | BIOGEN INCput | $38,006,000 | -38.4% | 1,263 | -27.7% | 8.36% | +5.9% | |
ODT | Sell | ODONATE THERAPEUTICS INC | $14,355,000 | +41.2% | 518,125 | -1.1% | 3.16% | +142.7% |
Sell | ASTRAZENECA PLCput | $12,579,000 | -11.8% | 3,312 | -8.1% | 2.77% | +51.6% | |
Sell | SAREPTA THERAPEUTICS INCput | $9,429,000 | -35.7% | 864 | -4.8% | 2.07% | +10.5% | |
Sell | AMARIN CORPORATION PLCcall | $6,074,000 | -62.0% | 4,463 | -54.6% | 1.34% | -34.7% | |
Sell | ASTRAZENECA PLCcall | $5,640,000 | -62.8% | 1,485 | -61.2% | 1.24% | -36.0% | |
Sell | SPDR S&P BIOTECHcall | $4,979,000 | -72.4% | 694 | -63.1% | 1.10% | -52.5% | |
Sell | FIBROGEN INCput | $4,235,000 | -51.7% | 915 | -36.6% | 0.93% | -16.9% | |
Sell | ZOGENIX INCcall | $3,613,000 | -72.4% | 991 | -62.4% | 0.80% | -52.5% | |
XERS | Sell | XERIS PHARMACEUTICALS INC | $3,450,000 | -59.7% | 202,916 | -58.3% | 0.76% | -30.7% |
Sell | NEKTAR THERAPEUTICSput | $2,685,000 | -90.6% | 817 | -82.6% | 0.59% | -83.8% | |
NKTR | Sell | NEKTAR THERAPEUTICS | $2,594,000 | -85.6% | 78,915 | -73.3% | 0.57% | -75.2% |
UMRX | Sell | UNUM THERAPEUTICS INC | $1,966,000 | -64.7% | 446,814 | -17.5% | 0.43% | -39.4% |
Sell | AVEO PHARMACEUTICALS INCcall | $1,717,000 | -57.4% | 10,731 | -11.9% | 0.38% | -26.7% | |
SLNO | Sell | SOLENO THERAPEUTICS INC | $906,000 | -44.5% | 529,921 | -29.8% | 0.20% | -4.8% |
MDGSW | Sell | MEDIGUS LTD*w | $522,000 | -43.6% | 1,043,764 | -17.7% | 0.12% | -2.5% |
ZSAN | Sell | ZOSANO PHARMA CORP | $355,000 | -97.1% | 167,403 | -33.2% | 0.08% | -95.1% |
RKDA | Sell | ARCADIA BIOSCIENCES INC | $303,000 | -77.6% | 95,682 | -65.5% | 0.07% | -61.3% |
Sell | MANNKIND CORPput | $253,000 | -80.7% | 2,388 | -66.6% | 0.06% | -66.5% | |
NOVN | Sell | NOVAN INC | $177,000 | -74.7% | 213,064 | -15.1% | 0.04% | -56.7% |
CHFS | Sell | CHF SOLUTIONS INC | $108,000 | -78.4% | 221,033 | -47.8% | 0.02% | -62.5% |
CHEKZ | Sell | CHECK CAP LTD*w | $101,000 | -56.1% | 252,155 | -17.8% | 0.02% | -24.1% |
NSPR | Sell | INSPIREMD INC | $89,000 | -62.3% | 560,562 | -47.7% | 0.02% | -33.3% |
SNES | Sell | SENESTECH INC | $86,000 | -87.3% | 146,530 | -85.0% | 0.02% | -77.9% |
Sell | MARINUS PHARMACEUTICALS INCcall | $82,000 | -94.9% | 287 | -82.0% | 0.02% | -91.2% | |
APOP | Sell | CELLECT BIOTECHNOLOGY LTDads | $84,000 | -79.6% | 40,032 | -53.7% | 0.02% | -66.0% |
Sell | VIKING THERAPEUTICS INCcall | $77,000 | -91.8% | 100 | -81.5% | 0.02% | -85.8% | |
SGLBW | Sell | SIGMA LABS INC*w | $74,000 | -14.9% | 188,813 | -32.7% | 0.02% | +45.5% |
BIOC | Sell | BIOCEPT INC | $49,000 | -87.5% | 57,505 | -59.6% | 0.01% | -78.0% |
CHEK | Sell | CHECK CAP LTD | $37,000 | -89.8% | 16,979 | -81.3% | 0.01% | -82.6% |
Sell | FUELCELL ENERGY INCput | $31,000 | -91.7% | 565 | -83.8% | 0.01% | -85.4% | |
ONTXW | Sell | ONCONOVA THERAPEUTICS INC*w | $26,000 | -61.2% | 660,970 | -0.7% | 0.01% | -33.3% |
Sell | DURECT CORPcall | $27,000 | -60.9% | 549 | -12.4% | 0.01% | -33.3% | |
Sell | PLURISTEM THERAPEUTICS INCput | $24,000 | -41.5% | 309 | -1.0% | 0.01% | 0.0% | |
KTOV | Sell | KITOV PHARMA LTD. | $13,000 | -72.3% | 19,980 | -26.1% | 0.00% | -50.0% |
SOLOW | Sell | ELECTRAMECCANICA VEHICLES CORP*w | $14,000 | -63.2% | 30,905 | -69.4% | 0.00% | -40.0% |
SCYX | Sell | SCYNEXIS INC | $8,000 | -84.0% | 15,764 | -62.1% | 0.00% | -66.7% |
Sell | CONATUS PHARMACEUTICALS INCcall | $0 | -100.0% | 187 | -57.2% | 0.00% | -100.0% | |
NSPRZ | Sell | INSPIREMD INC*w | $2,000 | -71.4% | 1,432,133 | -22.5% | 0.00% | -100.0% |
NSPRW | Exit | INSPIREMD INC*w | $0 | – | -498,797 | -100.0% | 0.00% | – |
APDNW | Sell | APPLIED DNA SCIENCES INC*w | $2,000 | -98.5% | 602,062 | -2.3% | 0.00% | -100.0% |
Exit | HELIOS AND MATHESON ANALYTICS INCcall | $0 | – | -125 | -100.0% | 0.00% | – | |
CYTXW | Exit | CYTORI THERAPEUTICS*w | $0 | – | -37,793 | -100.0% | 0.00% | – |
KOOL | Exit | CESCA THERAPEUTICS INC | $0 | – | -19,988 | -100.0% | -0.00% | – |
SBOT | Exit | STELLAR BIOTECHNOLOGIES INC | $0 | – | -46,859 | -100.0% | -0.01% | – |
YTEN | Exit | YIELD10 BIOSCIENCE INC | $0 | – | -47,740 | -100.0% | -0.01% | – |
RXIIW | Exit | RXI PHARMACEUTICALS*w | $0 | – | -195,259 | -100.0% | -0.01% | – |
SLS | Exit | SELLAS LIFE SCIENCES GROUP INC | $0 | – | -78,294 | -100.0% | -0.01% | – |
Exit | ADVERUM BIOTECHNOLOGIES INCput | $0 | – | -168 | -100.0% | -0.01% | – | |
TROV | Exit | TROVAGENE INC | $0 | – | -153,638 | -100.0% | -0.02% | – |
OVAS | Exit | OVASCIENCE INC | $0 | – | -255,803 | -100.0% | -0.02% | – |
HEB | Exit | HEMISPHERX BIOPHARMA INC | $0 | – | -1,143,632 | -100.0% | -0.03% | – |
INSM | Exit | INSMED INC | $0 | – | -15,000 | -100.0% | -0.04% | – |
TTNP | Exit | TITAN PHARMACEUTICALS INC | $0 | – | -1,518,294 | -100.0% | -0.04% | – |
MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -1,500 | -100.0% | -0.04% | – |
AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -135,272 | -100.0% | -0.04% | – |
Exit | SOPHIRIS BIO INCput | $0 | – | -1,578 | -100.0% | -0.06% | – | |
BPTH | Exit | BIO PATH HOLDINGS INC | $0 | – | -970,877 | -100.0% | -0.06% | – |
PTI | Exit | PROTEOSTASIS THERAPEUTICS INC | $0 | – | -199,900 | -100.0% | -0.06% | – |
Exit | ALDEYRA THERAPEUTICS INCcall | $0 | – | -427 | -100.0% | -0.08% | – | |
GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -44,136 | -100.0% | -0.08% | – |
EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -76,740 | -100.0% | -0.10% | – |
OPNT | Exit | OPIANT PHARMACEUTICALS INC | $0 | – | -43,736 | -100.0% | -0.10% | – |
RIBT | Exit | RICEBRAN TECHNOLOGIES | $0 | – | -281,061 | -100.0% | -0.10% | – |
Exit | INSMED INCput | $0 | – | -412 | -100.0% | -0.11% | – | |
MDGS | Exit | MEDIGUS LTDads | $0 | – | -296,712 | -100.0% | -0.13% | – |
APTX | Exit | APTINYX INC | $0 | – | -41,037 | -100.0% | -0.15% | – |
Exit | ADVERUM BIOTECHNOLOGIES INCcall | $0 | – | -2,230 | -100.0% | -0.17% | – | |
FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -155,044 | -100.0% | -0.24% | – |
Exit | AMICUS THERAPEUTICS INCput | $0 | – | -1,656 | -100.0% | -0.26% | – | |
Exit | ALKERMES PLCcall | $0 | – | -571 | -100.0% | -0.31% | – | |
SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -156,913 | -100.0% | -0.34% | – |
VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -163,463 | -100.0% | -0.36% | – |
Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -2,350 | -100.0% | -0.36% | – | |
ONS | Exit | ONCOBIOLOGICS INC | $0 | – | -3,354,909 | -100.0% | -0.42% | – |
Exit | GLOBAL BLOOD THERAPEUTICS INCcall | $0 | – | -1,312 | -100.0% | -0.64% | – | |
Exit | SANGAMO THERAPEUTICS INCput | $0 | – | -3,098 | -100.0% | -0.67% | – | |
Exit | FIBROGEN INCcall | $0 | – | -916 | -100.0% | -0.71% | – | |
Exit | VIKING THERAPEUTICS INCput | $0 | – | -3,873 | -100.0% | -0.86% | – | |
Exit | TILRAY INCput | $0 | – | -1,062 | -100.0% | -1.95% | – | |
Exit | ISHARES RUSSELL 2000call | $0 | – | -2,115 | -100.0% | -4.56% | – | |
Exit | ISHARES RUSSELL 2000put | $0 | – | -4,000 | -100.0% | -8.63% | – | |
Exit | SPDR S&P 500call | $0 | – | -4,001 | -100.0% | -14.88% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.